Related Experiment Videos

Human liver-derived cells stably modified for regulated proinsulin secretion function as bioimplants in vivo

Xiang Chen1, Jawahar G Patil, Serene H L Lok

  • 1Division of Medical Sciences, National Cancer Centre, Singapore and Department of Biochemistry, National University of Singapore, Singapore.

Summary

Researchers engineered liver cells to produce insulin, offering a potential new treatment for diabetes. These modified cells demonstrated stable insulin production in lab tests and in animal models, paving the way for future bioimplant therapies.

Related Concept Videos